Laboratory Animal Center, Dalian Medical University, Dalian 116044, People's Republic of China.
Biochem Biophys Res Commun. 2011 Jun 10;409(3):532-8. doi: 10.1016/j.bbrc.2011.05.039. Epub 2011 May 12.
Hepatic steatosis is considered to have an important impact on liver tumorigenesis, despite a lack of clear experimental evidence. Histopathological analysis of H-ras12V transgenic mice showed liver lesions on a steatosis background had significantly higher incidence than on a non-steatosis background. Further investigation showed that apolipoprotein A-I was elevated and accumulated around fatty vacuoles. This elevated level of apolipoprotein A-I was coupled with an elevated level of H-ras12V protein and ROS. In conclusion, our results suggest that the expression of H-ras12V oncogene leads to elevated levels of ROS and apolipoprotein A-I that contribute to steatosis. The steatosis, in turn, promotes the development of hepatic lesions induced by H-ras12V oncogene.
肝脂肪变性被认为对肝肿瘤发生有重要影响,尽管缺乏明确的实验证据。H-ras12V 转基因小鼠的组织病理学分析显示,在脂肪变性背景下的肝病变发生率明显高于非脂肪变性背景。进一步的研究表明载脂蛋白 A-I 升高并在脂肪空泡周围积累。这种载脂蛋白 A-I 的升高水平与 H-ras12V 蛋白和 ROS 的升高水平相关。总之,我们的结果表明,H-ras12V 癌基因的表达导致 ROS 和载脂蛋白 A-I 的水平升高,从而导致脂肪变性。反过来,脂肪变性促进了 H-ras12V 癌基因诱导的肝病变的发展。